Financials

News Discussions Technicals Forecast Seasonals Options

RAPP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Rapport Therapeutics, Inc. operating, investing, and financing activities

RAPP free cash flow for Q4 24 is -14.67 M USD. For 2024, RAPP free cash flow was -67.23 M USD and operating cash flow was -64.83 M USD.

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—